Express Plumbing, Heating, Cooling, & Roofing: A Leading HVAC Contractor Providing Efficient Air Conditioning and Heating System Solutions in Oceanport, NJ

Oceanport, NJ – Express Plumbing, Heating, Cooling, & Roofing, a trusted HVAC contractor Oceanport serves the locals with top-tier heating and cooling solutions. The company’s highly trained team is committed to providing dependable services for both residential and commercial clients, ensuring optimal comfort throughout the year. Whether it involves installing new air conditioning systems or […]

Rapid Alarms: Trusted Security System Supplier in Osborne Park, Perth

Osborne Park, Perth – Since 2012, Rapid Alarms has been a leading provider of security systems in the Perth Metro Area, specialising in the installation of commercial CCTV systems, alarm systems, access control solutions, and intercoms. As a trusted security system supplier, Rapid Alarms offers businesses in the region the latest technologies and a wide

Security Solar Powers Round Rock with Expert Solar Installations and Renewable Energy Solutions

Round Rock, TX – Security Solar, a trusted name in the solar industry since 2004, offers high-quality solar panel installations and energy services across Round Rock, Austin, and the surrounding areas. With a focus on energy independence and sustainability, Security Solar ensures that residential and commercial properties benefit from efficient solar systems tailored to their

OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution

OCI Global (Euronext: OCI), (“OCI,” the “Company”) announces today that it will pay a USD 700 million distribution (USD 3.31 per share) on 5 September 2025 through a mix of capital repayment and extraordinary cash dividend. This distribution is pursuant to the resolutions adopted at OCI's annual general meeting on 21 May and will follow

Certara Simcyp(R) Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

(NASDAQ:CERT), RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp(R) Simulator for use in regulatory submissions across the EU. Certara is the first company to receive EMA qualification for a PBPK modeling platform, and Simcyp is

Network API Revenue to Exceed $8 Billion by 2030 Globally, as KYC Identified as the Next Major Opportunity

HAMPSHIRE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) — A new study from Juniper Research, the foremost experts in telecommunications and connectivity markets, has found operator revenue from network Application Programming Interfaces (APIs) globally will exceed $8 billion by 2030. This is a substantial increase from the $284 million operators are forecasted to generate in

Network API Revenue to Exceed $8 Billion by 2030 Globally, as KYC Identified as the Next Major Opportunity

Network API Revenue to Exceed $8 Billion by 2030 Globally, as KYC Identified as the Next Major Opportunity GlobeNewswire August 04, 2025 HAMPSHIRE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) — A new study from Juniper Research, the foremost experts in telecommunications and connectivity markets, has found operator revenue from network Application Programming Interfaces (APIs)

Certara Simcyp(R) Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Simcyp(R) Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling GlobeNewswire August 04, 2025 RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp(R) Simulator for use in regulatory submissions

Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225) has been approved to initiate by both China's National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). The trial will evaluate cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific antibody, in combination with lenvatinib versus lenvatinib

'Waste-to-Value, Industry Upgrade, and GBA Co-Creation' Technology Forum Brings Together Top Experts, Driving Green Industry Advancement Through Frontier Technologies

The "Waste-to-Value, Industry Upgrade, and GBA Co-Creation" Technology Forum (the "Forum"), jointly organized by the GBA Economic and Trade Association, GBA Institute, All-China Environment Federation, and "The Hong Kong University of Science and Technology (HKUST) – Abs-lute Pure EnviroSci Limited (APEL) Joint Laboratory on Health and Environmental Innovation" under APEL, was successfully convened on 29

Scroll to Top